Clinical Trial Update: Dose Finding Study Of CP-870,893, An Immune System Stimulating Antibody, In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

The Phase 1 dose-finding study of CP-870,893 in combination with paclitaxel and carboplatin for patients with metastatic solid tumors has completed, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CP-870,893 (CD40 agonist monoclonal antibody)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2012-10-31